Toxoplasma, Toxoplasmosis, Congenital Toxoplasmosis, Public Health, SchizophreniaToxoplasma, Toxoplasmosis, Toxoplasmosis Congénita, Salud Pública, Esquizofrenia

1. Ministerio de Salud y Protección social de Colombia. Guía de práctica clínica para el diagnóstico, tratamiento e inicio de la rehabilitación social de los adultos con esquizofrenia: guía para profesionales de la salud [internet]. Bogotá; 2014. Disponible en: https://www.medicosgeneralescolombianos.com/images/Guias_2014/GPC_29_Esquizofrenia.pdf
2. Murphy S, Irving CB, Adams CE, Driver R. Crisis intervention for people with severe mental illnesses. En: Murphy S, editor. Cochrane database of systematic reviews. Chichester, UK: John Wiley & Sons, Ltd; 2012. p. CD001087.
3. Malone D, Marriott SVL, Newton-Howes G, Simmonds S, Tyrer P. Community mental health teams (CMHTs) for people with severe mental illnesses and disordered personality. Cochrane Database Syst Rev. 2007 Jul 18;(3):CD000270. https://doi.org/10.1002/14651858.CD000270.pub2
4. Andreasen NC. Schizophrenia: the fundamental questions. Brain Res Rev. 2000 Mar 1;31(2-3):106-12. https://doi.org/10.1016/s0165-0173(99)00027-2
5. Li Y, Weber NS, Fisher JA, Yolken RH, Cowan DN, Larsen RA, et al. Association between antibodies to multiple infectious and food antigens and new onset schizophrenia among US military personnel. Schizophr Res. 2013 Dec;151(1-3):36-42. https://doi.org/10.1016/j.schres.2013.10.00
6. Krause D, Matz J, Weidinger E, Wagner J, Wildenauer A, Obermeier M, et al. The association of infectious agents and schizophrenia. World J Biol Psychiatry. 2010 Aug;11(5):739-43.
7. Hayes LN, Severance EG, Leek JT, Gressitt KL, Rohleder C, Coughlin JM, et al. Inflammatory molecular signature associated with infectious agents in psychosis. Schizophr Bull. 2014 Sep;40(5):963-72.
8. Park MH, Kwon YJ, Jeong HY, Lee HY, Hwangbo Y, Yoon HJ, et al. Association between Intracellular Infectious Agents and Schizophrenia. Clin Psychopharmacol Neurosci. 2012 Aug;10(2):117-23. https://doi.org/10.9758/cpn.2012.10.2.117
9. Wang HL, Wang GH, Li QY, Shu C, Jiang MS, Guo Y. Prevalence of Toxoplasma infection in first-episode schizophrenia and comparison between Toxoplasma-seropositive and Toxoplasma-seronegative schizophrenia. Acta Psychiatr Scand. 2006 Jul;114(1):40-8. https://doi.org/10.1111/j.1600-0447.2006.00780.x
10. Holub D, Flegr J, Dragomirecka E, Rodriguez M, Preiss M, Novak T, et al. Differences in onset of disease and severity of psychopathology between toxoplasmosis-related and toxoplasmosis-unrelated schizophrenia. Acta Psychiatr Scand. 2013 Mar;127(3):227-38. https://doi.org/10.1111/acps.12031
11. Bhadra R, Cobb DA, Weiss LM, Khan IA. Psychiatric disorders in toxoplasma seropositive patients--the CD8 connection. Schizophr Bull. 2013 May;39(3):485-9.
12. Jauhar S, Johnstone M, McKenna PJ. Schizophrenia. The Lancet. 2022;399(10323):473-86.
13. Robert-Gangneux F, Dardé ML. Epidemiology of and diagnostic strategies for toxoplasmosis. Clin Microbiol Rev. 2012 Apr 1;25(2):264-96. https://doi.org/10.1128/CMR.05013-11
14. Dard C, Fricker-Hidalgo H, Brenier-Pinchart MP, Pelloux H. Relevance of and new developments in serology for toxoplasmosis. Trends Parasitol. 2016 Jun 1;32(6):492-506.
15. Ahmadpour E, Daryani A, Sharif M, Sarvi S, Aarabi M, Mizani A, et al. Toxoplasmosis in immunocompromised patients in Iran: a systematic review and meta-analysis. J Infect Dev Ctries. 2014 Dec 15;8(12):1503-10.
16. Henriquez SA, Brett R, Alexander J, Pratt J, Roberts CW. Neuropsychiatric disease and Toxoplasma gondii infection. Neuroimmunomodulation. 2009;16(2):122-33. https://doi.org/10.1159/000180267
17. Khandaker GM, Zimbron J, Lewis G, Jones PB. Prenatal maternal infection, neurodevelopment and adult schizophrenia: a systematic review of population-based studies. Psychol Med. 2013 Feb;43(2):239-57.
18. Brown Jr. JS. Association of increased prenatal estrogen with risk factors for schizophrenia. Schizophr Bull. 2011;37(5):946-9. https://doi.org/10.1093/schbul/sbp161
19. Brown AS, Schaefer CA, Quesenberry CPJ, Liu L, Babulas VP, Susser ES. Maternal exposure to toxoplasmosis and risk of schizophrenia in adult offspring. Am J Psychiatry. 2005 Apr;162(4):767-73.
20. Buka SL, Tsuang MT, Torrey EF, Klebanoff MA, Bernstein D, Yolken RH. Maternal infections and subsequent psychosis among offspring. Arch Gen Psychiatry. 2001 Nov;58(11):1032-7. https://doi.org/10.1001/archpsyc.58.11.1032
21. Blomström Å, Gardner RM, Dalman C, Yolken RH, Karlsson H. Influence of maternal infections on neonatal acute phase proteins and their interaction in the development of non-affective psychosis. Transl Psychiatry. 2015;5:e502-e502.
22. Brown AS. Prenatal infection as a risk factor for schizophrenia. Schizophr Bull. 2006 Apr;32(2):200-2. https://doi.org/10.1093/schbul/sbj052
23. Notarangelo FM, Wilson EH, Horning KJ, Thomas MAR, Harris TH, Fang Q, et al. Evaluation of kynurenine pathway metabolism in Toxoplasma gondii-infected mice: implications for schizophrenia. Schizophr Res. 2014 Jan;152(1):261-7.
24. Gaskell EA, Smith JE, Pinney JW, Westhead DR, McConkey GA. A unique dual activity amino acid hydroxylase in Toxoplasma gondii. PloS One. 2009;4(3). https://doi.org/10.1371/JOURNAL.PONE.0004801
25. Flegr J. Schizophrenia and Toxoplasma gondii: an undervalued association? Vol. 13, Expert review of anti-infective therapy. England; 2015. p. 817-20.
26. Nimgaonkar VL, Yolken RH. Neurotropic infectious agents and cognitive impairment in schizophrenia. Schizophr Bull. 2012;38(6):1135-6.
27. Brown AS. Exposure to prenatal infection and risk of schizophrenia. Front Psychiatry. 2011;2:63. https://doi.org/10.3389/fpsyt.2011.00063
28. Khademvatan S, Saki J, Khajeddin N, Izadi-Mazidi M, Beladi R, Shafiee B, et al. Toxoplasma gondii exposure and the risk of schizophrenia. Jundishapur J Microbiol. 2014 Nov;7(11):e12776.
29. Omar A, Bakar OC, Adam NF, Osman H, Osman A, Suleiman AH, et al. Seropositivity and serointensity of Toxoplasma gondii antibodies and DNA among patients with schizophrenia. Korean J Parasitol. 2015 Feb;53(1):29-34. https://doi.org/10.3347/kjp.2015.53.1.29
30. Brown AS, Vinogradov S, Kremen WS, Poole JH, Deicken RF, Penner JD, et al. Prenatal exposure to maternal infection and executive dysfunction in adult schizophrenia. Am J Psychiatry. 2009 Jun;166(6):683-90.
31. Mortensen PB, Norgaard-Pedersen B, Waltoft BL, Sorensen TL, Hougaard D, Torrey EF, et al. Toxoplasma gondii as a risk factor for early-onset schizophrenia: analysis of filter paper blood samples obtained at birth. Biol Psychiatry. 2007 Mar;61(5):688-93. https://doi.org/10.1016/j.biopsych.2006.05.024
32. Daryani A, Sharif M, Hosseini SH, Karimi SA, Gholami S. Serological survey of Toxoplasma gondii in schizophrenia patients referred to Psychiatric Hospital, Sari City, Iran. Trop Biomed [internet]. 2010;27(3):476-82. Disponible en: https://pubmed.ncbi.nlm.nih.gov/21399589/
33. Cetinkaya Z, Yazar S, Gecici O, Namli MN. Anti-Toxoplasma gondii antibodies in patients with schizophrenia--preliminary findings in a Turkish sample. Schizophr Bull. 2007 May;33(3):789-91.
34. Yuksel P, Alpay N, Babur C, Bayar R, Saribas S, Karakose AR, et al. The role of latent toxoplasmosis in the aetiopathogenesis of schizophrenia--the risk factor or an indication of a contact with cat? Folia Parasitol (Praha). 2010 Jun;57(2):121-8.
35. Nascimento FS, de Rosalmeida Dantas C, Netto MP, Mella LFB, Suzuki LA, Banzato CEM, et al. Prevalence of antibodies to Toxoplasma gondii in patients with schizophrenia and mood disorders. Schizophr Res. 2012 Dec;142(1-3):244-5. https://10.1016/j.schres.2012.08.036
36. Torrey EF, Yolken RH. Toxoplasma gondii and schizophrenia. Emerg Infect Dis. 2003 Nov;9(11):1375-80.
37. Celik T, Kartalci S, Aytas O, Akarsu GA, Gozukara H, Unal S. Association between latent toxoplasmosis and clinical course of schizophrenia - continuous course of the disease is characteristic for Toxoplasma gondii-infected patients. Folia Parasitol (Praha). 2015 Jan;62. https://doi.org/10.14411/fp.2015.015
38. Hamidinejat H, Ghorbanpoor M, Hosseini H, Alavi SM, Nabavi L, Jalali MHR, et al. Toxoplasma gondii infection in first-episode and inpatient individuals with schizophrenia. Int J Infect Dis. 2010 Nov;14(11):e978-81. https://doi.org/10.1016/j.ijid.2010.05.018
39. Esshili A, Thabet S, Jemli A, Trifa F, Mechri A, Zaafrane F, et al. Toxoplasma gondii infection in schizophrenia and associated clinical features. Psychiatry Res. 2016 Nov;245:327-32.
40. Chen X, Chen B, Hou X, Zheng C, Yang X, Ke J, et al. Association between Toxoplasma gondii infection and psychiatric disorders in Zhejiang, Southeastern China. Acta Trop. 2019 Apr 1;192:82-6.
41. Galli L, Del Grande C, Rindi L, Mangia C, Mangano V, Schiavi E, et al. Lack of circulating toxoplasma gondii DNA in seropositive patients with bipolar or schizophrenia spectrum disorders. Psychiatry Res. 2019 Mar 1;273:706-11.
42. Burgdorf KS, Trabjerg BB, Pedersen MG, Nissen J, Banasik K, Pedersen OB, et al. Large-scale study of Toxoplasma and cytomegalovirus shows an association between infection and serious psychiatric disorders. Brain Behav Immun. 2019 Jul 1;79:152-8.
43. Karlsson H, Dalman C. Epidemiological Studies of Prenatal and Childhood Infection and Schizophrenia. Curr Top Behav Neurosci. 2020;44:35-47. https://doi.org/10.1007/7854_2018_87
44. Wang AW, Avramopoulos D, Lori A, Mulle J, Conneely K, Powers A, et al. Genome-wide association study in two populations to determine genetic variants associated with Toxoplasma gondii infection and relationship to schizophrenia risk. Prog Neuropsychopharmacol Biol Psychiatry. 2019 Jun 8;92:133-47.
45. Torrey EF, Yolken RH. Schizophrenia as a pseudogenetic disease: A call for more gene-environmental studies. Psychiatry Res. 2019 Aug 1;278:146-50.
46. Prata DP, Costa-Neves B, Cosme G, Vassos E. Unravelling the genetic basis of schizophrenia and bipolar disorder with GWAS: A systematic review. J Psychiatr Res. 2019;114:178-207. https://doi.org/10.1016/j.jpsychires.2019.04.007
47. Chen Q, Li D, Jin W, Shi Y, Li Z, Ma P, et al. Research progress on the correlation between epigenetics and schizophrenia. Front Neurosci. 2021;15:784. https://doi.org/10.3389/fnins.2021.688727
48. Forero DA, González-Giraldo Y. Integrative in silico analysis of genome-wide DNA methylation profiles in schizophrenia. J M Neurosci. 2020;70(11):1887-93. https://doi.org/10.1007/s12031-020-01585-w
49. Tao R, Davis KN, Li C, Shin JH, Gao Y, Jaffe AE, et al. GAD1 alternative transcripts and DNA methylation in human prefrontal cortex and hippocampus in brain development, schizophrenia. Mol Psychiatry. 2018;23(6):1496-505. https://doi.org/10.1038/mp.2017.105
50. Bigna JJ, Tochie JN, Tounouga DN, Bekolo AO, Ymele NS, Youda EL, et al. Global, regional, and country seroprevalence of Toxoplasma gondii in pregnant women: a systematic review, modelling and meta-analysis. Sci Rep. 2020;10(1):1-10. https://doi.org/10.1038/s41598-020-69078-9 49

Vol. 64 Núm. 2 (2023)